2008 NSTI Nanotechnology Conference and Trade Show - Nanotech 2008 - 11th Annual
Technical Conferences
Merck Corporate Needs
NanoInk Symposium
Nano Electronics & Photonics
Nano Fabrication
MEMS & NEMS
Sensors & Systems
Micro & Nano Fluidics
MSM - Modeling Microsystems
WCM - Compact Modeling
Nanostructured Materials & Devices
Soft Nanotechnologies & Applications
Nanoparticles in Soft Materials - Colloidal Systems
Polymer Nanotechnology
Carbon Nano Structures & Devices
Nano Particles & Applications
Composites
Nanostructured Surfaces and Interfaces
Nanoscale Characterization
Energy Technologies & Applications
Nanotech in Health, Environment & Society
ICCN - Nanoscale Modeling
Nanoreliability
Bio Nano Materials & Tissues
Bio Sensors & Diagnostics
Biomarkers & Nanoparticles
Cancer Diagnostics, Imaging & Treatment
Drug Delivery & Therapeutics
Nano Medicine
Nanotech to Neurology
Phage Nanobiotechnology
Clean Technology 2008
Industrial Impact Workshop
Confirmed Speakers
Program Committee
Reviewers

Partnering Events:

TechConnect Summit
Clean Technology 2008

Biomarkers & Nanoparticles

Biomarkers & Nanoparticles

Symposium Chair

Srinivas Iyer Srinivas Iyer
Los Alamos National Laboratory, US

Symposium Sessions

 

Monday June 2

1:30 Nanoparticles: Nanoparticles for Biology and Medicine
 Biomarkers & Nanoparticles
 

Tuesday June 3

 Drug Delivery & Theraputics
 Merck Innovation Symposium: siRNA Delivery
3:30 Soft Nano: Biologically inspired nanostructures
3:30 Soft Nano: Particles: Understanding and controling stability in Soft Nanocomposites - 2
3:30 Merck Innovation Symposium: siRNA Delivery
 

Wednesday June 4

 

Thursday June 5

8:30 Biomarkers and Nanoparticles
10:30 Drug and Gene Delivery Systems
 

Symposium Program

 

Monday June 2

Back to Top
1:30 Nanoparticles: Nanoparticles for Biology and MedicineRoom 203
 Session chair: Srinivas Iyer, LANL, US
1:30 Effect of Medical Device Substrate Material on Nanoparticulate Silver Efficacy
B.J. Dair, K.M. Kennedy, R.S. Casas, FDA, US
1:50 The Use of Gold-Citrate Nanoparticles and Curcumin Nanomedicine to Target Cancer at a Single Cell Level
A. Moten, Harvard University, US
2:10 Combinatorial optimization, a paradigm shift in targeted particle drug delivery development
J. Wright, BIND, US
2:30 Nanomaterial: A realistic business case for Pharma
T.H. Keller, GlaxoSmithKline, UK
2:50 Towards nanosized particles in pharmaceutical industry
N.R. Bieri, U. Meier, E. Goncalves, D. Zimmermann, M. Juhnke, R. Thakur, Novartis Pharma AG, CH
Back to Top
Biomarkers & NanoparticlesExhibit Hall C
- Reactive Nanoparticles to Mitigate Chemical Contamination for Homeland Security
O.B. Koper, F. Kroh, H. Kwen, S. Rajagopalan, NanoScale Corporation, US
- Optimizing nanoparticle functionalization for quantum dot formation
J.B. Hooper, D. Bedrov, G.D. Smith, H. Kim, University of Utah, US
- Chip-Based Energy Transfer System between Quantum dots and Gold Nanoparticles for Analysis of Protein Glycosylation
Y-P. Kim, S. Park, E. Oh, Y-H. Oh, H-S. Kim, KAIST, KR
- Functionalized Mesoporous Silica Nano-particle for Optical Bio-detection
W.C. Maki, N.N. Mishra, B. Filanoski, S.K. Rastogi, E. Cameron, G. Maki, University of Idaho, US
- Directed Self-Assembly of Bio-Derivatized Nanoparticles into Micron Size Biosensor Devices
M.J. Heller, D. Dehlinger, S. Esener, A. Hsiao, University of California, San Diego, US
- Inhibition of Acetylcholine Esterase Promotes Growth of Silver Nanoparticles: Direct method to Sense Nerve Gases Using Nanotechnology
A. Virel, L.S. Peña, V. Pavlov, CIC Biomagune, ES
- Use of Nanoparticles for Signal Amplification
A. Virel, L.S. Peña, V. Pavlov, CIC Biomagune, ES
- Characterization of magnetotactic bacteria from marine environment of Colombia
S.P. Grisales, V.K. Morillo, M.A. Márquez, A. Morales, U. Lins, Universidad Nacional de Colombia, CO
- Local temperature measurement near remotely heated,ultra-small gold nanoparticles
A. Gupta, H. Denver, D-A Borca-Tasciuc, A. Joshi, R. Kane, M. Hella, Rensselaer Polytechnic Institute, US
- Liposome-Quantum Dot Hybrids as Multimodal Therapeutic & Imaging Agent Delivery Systems
W.T. Al-Jamal, K.T. Al-Jamal, K. Kostarelos, Nanomedicine Laboratory, UK
- Nanoparticles for imaging of transmembrane potential
R.A. Khatchadourian, S.J. Clarke, C. Hollmann, J.L. Nadeau, McGill University, CA
- Gold Nanoparticle Bioconjugates for Biomolecular Imaging and Detection
X. Liu, Q. Dai, J. Coutts, L. Austin, G. Knowles, Q. Huo, University of Central Florida, US
- Human monocyte uptake and carriage of IgG-coated nanoparticles to neuroinflamed brain subregions
A. Béduneau, H. Dou, C. Grotepas, M. Boska, N. Gong, A.V. Kabanov, H.E. Gendelman, University of Nebraska, US
- Dye Coded Nanoparticle as SERRS Labels for Ultrasensitive Detection of Proteins and Antibodies
R. Stevenson, R.J. Stokes, A. Ingram, K. Faulds, D. Graham, The University of Strathclyde, UK
- Functionalized Inorganic Nanostructures for Biomedical Applications
K. Bonroy, H. Jans, B. Van de Broek, K. Jans, G. Reekmans, A. Van Summeren, B. Van Meerbergen, C. Huang, T. Stakenborg, J. Trekker, M. Willems, C. Bartic, K. Verhaegen and G. Borghs, IMEC, BE
- Enrichment of serum phosphopeptide by nanoparticles to identify cancer biomarker
A. Shah, V. Sachdev, A. Bharti, Boston University Medical School, US
 

Tuesday June 3

Back to Top
Drug Delivery & TheraputicsExhibit Hall C
- Utility of Customized Targeted PEG Linkers for the delivery of oligonucleotides without the use of transfection reagents
H. Zhao, P. Reddy, J. Xia, M. Wang, P. Sapra, R. Bandaru, M. Belen Rubio, D. Wu, P. Zhu, D. Filpula, L.M. Greenberger, I.D. Horak, Enzon Pharmaceuticals, Inc., US
- Nanoparticles of the Thermo-mechanically Activated Zeolite in the Design and Synthesis of New Drugs Generation
S. Ivkovic, D. Brezak, MEGAMIN GmbH, DE
- Invention of Polysaccharide-base Nanoparticles for Enhancing Drug Permeability across the Blood Brain Barrier
E.S. Gil, T.L. Lowe, Pennsylvania State University, US
- Molecular Imaging by Nanoparticle Bacterial delivery Systems:
R. Sharma, University of North Carolina, Greensboro, US
- Influence of water-soluble polymers and surfactants, on mebendazole solubilization by _- and permethyl-_-cyclodextrins
O-M. Ba, M. Lahiani-Skiba, S. Joudieh, F. Bounoure, M. Skiba, Université de Rouen, FR
- Synthesis of magnetic nanoparticles and its applications in drug delivery systems
N. Wright Bolden, V. Rangari, S. Jeelani, Tuskegee University, US
- Organisation of peptide ligands on the surface of gene vectors
M. Wang, A.D. Miller, M. Thanou, Imperial College London, UK
- Micellar form of novel poorly soluble pro-apoptotic agent, N-([(2-hydroxy-5-nitrophenyl) amino] carbonothioyl}-3, 5-dimethylbenzamide (PIT) for effective targeting to solid tumors
I. Skidan, A. Degterev, P. Dholakia, V. Torchilin, Northeastern University, US
- TATp-bearing Immunoliposomes for In Vivo Gene Delivery to Ischemic Myocardium
Y.T. Ko, W.C. Hartner, A. Kale, V.P. Torchilin, Northeastern University, US
- Radiolabelled Microspheres As a Delivery System For Targetad Radiotherapy
G.P. Bandopadhyaya, J. Shukla, All India Institute of Medical Sciences, IN
- Lyceum Chinense and Calcium Phosphate Nanoparticles for Ophthalmic Drug Delivery
Q. He, Z. Fang, M. Wang, Q.W. Xu, R. Chen, X.Z. Zhang, W.M. Yaun, D.M. Zhau, Jian Wu, Morehouse School of Medicine, US
- Long-circulating PEGylated PLGA nanoparticles for Drug Delivery
J. Park, P.M. Fong, K.S. Russell, W.M. Saltzman, T.M. Fahmy, Carigent Therapeutics, US
- Encapsulation and Extended release of Anti-cancer Anastrozole by Stealth Nanoparticles
K. Sarkar, H. Yang, Virginia Commonwealth University, US
- How much advantage do Nanoscale Phenomena afford for Pulmonary Delivery?
N. Walji, M. Thanou, N. Quirke, Imperial College London, UK
- Evaluation of the paromomycin loading characteristics in nanoprecipitated PLGA nanospheres
S. Kalimouttou, M. Lahiani-Skiba, N. Naouli, V.S. LIN, M. Skiba, Université de Rouen, FR
- Preparation And Evaluation Of In Vitro Release Of Amphiphilic _-Cyclodextrin Or Pla Nanospheres Containing A Hydrophobic Drug
S. Lin, M. Lahiani-Skiba, N. Naouli, M. Skiba, Université de Rouen, FR
- Step and Flash Imprint Lithography for the Fabrication of Shape-specific, Enzymatically-triggered, Drug Nanocarriers
M. Caldorera-Moore, L.C. Glangchai, L. Shi, K. Roy, The University of Texas at Austin, US
- Layer-By-Layer Formation of Polymer Micro Capsules for Drug Delivery Application
A. Manju, K. Sreenivasan, Sree Chiotra Tirunal Institute for Medical Sciences and Technology, IN
- DNA-Associated Single-walled Carbon Nanotubes as a Platform for Drug Delivery
B.D. Dolash, R.R. Lahiji, D.Y. Zemlyanov, R. Reifenberger, D.E. Bergstrom, Purdue University, US
- Manufacture and in vitro efficacy of lymphoma-targeted doxorubicin-loaded PLGA nanoparticles
J. Lu, M. Nkansah, J. Park, P.M. Fong, Carigent Therapeutics, Inc., US
- High Fidelity Hompolymer Sequencing
S. Goel, P. Griffin, R.W. Davis, M. Ronaghi, Stanford University, US
- Studies of conformational changes induced in a carrier protein: Bovine serum albumin
N. El Kadi, N. Taulier, W. Urbach, M. Waks, Paris V, FR
- Real-time Detection and Quantitation of siRNAs in vivo
A. Cheng, Y. Liang, A. Vlassov, M. Li, Y. Wang, L. Wong, C. Chen, S. Magdaleno, Ambion Inc., An Applied Biosytems Business, US
- Nanoscale Aspects of Pharmaceutical Materials
Y. Yang, P. Schields, L. Brostrom, P. Tishmack, R. McClurg, I. Ivanisevic, S. Bates, J-O. Henck, D. Engers, SSCI, An Aptuit Company, US
Back to Top
Merck Innovation Symposium: siRNA DeliveryExhibit Hall C
- Labile Catalytic Packaging and Delivering of Short Interference RNA to Cancer Cells: Control of Gold Nanoparticles “out” of RNA Complexes
A.M. Chen, O. Taratula, D. Wei, T. Minko, H. He, Rutgers, The State of New Jersey, US
- In vitro transfection efficiency of chitosan nanoparticles for gene delivery
M. Malhotra, A. Kulamarva, S. Sebak, J. Bhathena, S. Prakash, McGill University, CA
- Toward in vivo Targeting Delivery of siRNA for Efficient Cancer Therapy
O. Taratula, P. Kirkpatrick, R. Salva, I. Pandya, T. Minko, H. He, Rutgers-Newark University, US
- SiRNA for Therapeutic Immuno-modulation: Simultaneous Delivery of Cytokine-targeted SiRNA and DNA Antigens to Dendritic Cells using Polymer Microcarriers
A. Singh, H. Nie, B. Ghosn, K. Roy, The University of Texas at Austin, US
- Multilayered ABCD Nanoparticles for siRNA delivery
M. Thanou, A. Miller, Imperial College London, UK
- Delivery systems for enhanced siRNA delivery
A-L. Bolcato-Bellemin, M-E. Bonnet, J-P. Behr, P. Erbacher, Polyplus-transfection, FR
Back to Top
3:30 Soft Nano: Biologically inspired nanostructuresRoom 202
 Session chair: Fiona Case, NSTI, USA
3:30 Biopolymerization-Driven Self-Assembly of Nanofiber Air-Bridges
S. Pabba, B.H. Fasciotto, M.M. Yazdanapanah, V.V. Dobrokhotov, R.W. Cohn, University of Louisville, US
3:50 Polymer Biomembranes
W. Meier, University of Basel, CH
4:20 Self-Assembly of Nanoporous Silica Colloids: from Fundamentals to Applications
I. Sokolov, Clarkson University, US
4:50 The Nanomechanical Testing and Characterisation of Anti-viral Nano-structured Surface Coatings
I. Singh, P.S. Allan, Brunel University, UK
Back to Top
3:30 Soft Nano: Particles: Understanding and controling stability in Soft Nanocomposites - 2Room 203
 Session chair: Peter Schurtenberger, University of Fribourg, CH
3:30 Influence of structural forces and contact hysteresis on flow-induced aggregation and breakage of polymer nanoparticles
A.S. Moussa, L. Ehrl, M. Soos, M. Lattuada, M. Morbidelli, ETH Zurich, CH
3:50 Redispersible hybrid nanopowders: cerium oxide nanoparticle complexes with phosphonated-peg oligomers
L. Qi, A. Sehgal, J.-C. Castaing, J. Fresnais, J.-F. Berret, J.-P. Chapel, Rhodia/CNRS joint Institution, US
4:10 Controlled Co-Assembly of Iron Oxide Nanoparticles and Polymers: Towards the Generation of Highly Persistent Superparamagnetic Nanorods
J. Fresnais, J.-F. Berret, B. Frka-Petesic, O. Sandre, R. Perzynski, Laboratoire Matière et Systèmes Complexes, FR
4:30 Scalability and Control of Electrophoretic Directed Assembly of Nanoparticles
C. Yilmaz, N-G Cha, S. Somu, A. Busnaina, Northeastern University, US
Back to Top
3:30 Merck Innovation Symposium: siRNA DeliveryRoom 208
3:30 Introduction: siRNA Delivery
A. Sachs, Merck, US
3:40 Development of a new RNAi therapeutics platform
J. Kamens, W. Salomon, H. Baigude, J. McCarroll, C.-S. Yang, P. Swain, T. Rana, T. Woolf, D. Samarsky, P. Pavco, RXi Pharmaceutical, US
4:00 Amphoteric liposomes are a platform for multi-organ delivery of oligonucleotides
C. Reinsch, U. Rauchhaus, S. Panzner, novosom AG, DE
4:20 Oral Delivery of Map4K4 siRNA to Macrophages Inhibits TNF alpha Production and Protects against a LPS-Galactosamine Challenge in Mice
M. Aouadi, G. Tesz, E. Soto, M. Wang, S. Nicoloro, G. Ostroff, M. Czech, University of Massachusetts Medical School, US
4:40 Systemic Delivery of Targeted, siRNA-Containing Nanoparticles for the Treatment of Solid Tumors: Concept to Clinic
J.D. Heidel, J.Y-C. Liu, R.K. Zeidan, Y. Liang, S. Rele, M.E. Davis, Calando Pharmaceuticals, US
5:00 Targeting and Delivery of siRNA using Nanoparticles Fabricated via the PRINT Process
D.A. Canelas, X. Gao, S. Tian, P.A. Ropp, J.M. DeSimone, University of North Carolina at Chapel Hill, US
5:20 Long-Circulating Micelle-like DNA-encapsulating Nanoparticles for Systemic Gene Delivery
Y.T. Ko, W.C.A. Kale, V.P. Torchilin, Northeastern University, US
5:40 Efficient siRNA Delivery by Secondary and Tertiary Amine Modified Polysaccharides
B. Ghosn, A. Singh, K. Roy, The University of Texas at Austin, US
 

Thursday June 5

Back to Top
8:30 Biomarkers and NanoparticlesRoom 308
 Session chair: Srinivas Iyer, LANL, US
8:30 Multiplexed Proteolytic Enzyme Assay Based on Energy Transfer between Quantum Dots and Gold Nanoparticles
Y.H. Oh, Y.P. Kim, H.S. Kim, Korea Abvanced Institute of science and Technology, KR
8:50 2-Nitroimidazole as Potential Nanoprobe in Hypoxia Imaging by MRI/PET
R. Sharma, A. Sharma, University of North Carolina, US
9:10 Biomolecular activity switch: an application of metallic nanoparticle plasmon resonance
J. Alper, A. Wijaya, M. Crespo, L. DeFlores, A. Tokmakoff, K. Hamad-Schifferli, Massachusetts Institute of Technology, US
9:30 Functional Nanoparticles for Biomedical Applications
Y. Durant, E. de Muinck, Nanostructured Polymers Research Center, US
9:50 Multifunctional nanoparticle platforms for pathogen diagnostic applications
A.J. Kell, C. Paquet, B. Simard, National Research Council, CA
Back to Top
10:30 Drug and Gene Delivery SystemsRoom 311
 Session chair: Steve Xanthoudakis, Merck, US
10:30 Cell-mediated, heat-based therapy for combating HIV infection
H.T. Denver, C.M. de Noronha, D.-A. Borca-Tasciuc, Rensselaer Polytechnic Institute, US
10:50 A broad-spectrum viricide and its application as a novel human anti-viral therapeutic system
E. Seymour, A. Diwan, V. Boniuk, R. Barton, NanoViricides, Inc., US
11:10 Gene Delivery and Transfection Studies with Lipopolyplexes in Human Endothelial and Smooth Muscle Cells
L. Brito, S. Little, R. Langer, M. Amiji, Northeastern University, US
11:30 A Micro-Implant based on MEMS (Micro-Electro-Mechanical-Sysems) Technology for Treatment of Hemorrhagic Shock in Ambulatory Settings
N.M. Elman, H-L. Ho Duc, M.J. Cima, Massachusttes Institute of Technology, US
11:50 Development of Peptide Nucleic Acid Assemblies for Application in Drug Delivery and Molecular Sensing
F.N. Butler, O. Elibol, B.D. Hines, B. Reddy Jr., R. Bashir, D.E. Bergstrom, Purdue University, US
 

Special Symposium

Nanodevices and nanoparticles enable study of a wide range of biological phenomena extending from protein-protein interaction mapping to cancer detection in intact animals and man. Recent advances in materials science, in particular the development of functionalized nanoparticles, united with advances in molecular imaging research, provide the impetus for the present explosion in nanobiotechnology imaging research.

Key to those advances is the emergence of functionalized nanoparticles, particularly quantum dots (QDs) that can be targeted specifically to receptors, enzymes, transporters and other molecules of biological importance that can interact at the cellular level. Additionally, over the last five years there has been a proliferation of high-resolution devices for in vivo imaging in animal models of human disease and high-throughput, i.e., microarray and combinatorial, techniques for generating new diagnostic and therapeutic targets and probes.

Nanotechnology in the Life-sciences is omnipresent. Several biological systems operate at the nanoscale with remarkable precision and regulation. A fine example is that of biomolecular motor proteins, designed by nature to carry out critical functions in the cell. Most of the properties of these proteins are nanoscale, be they size or time of operation. While systems such as motors have been isolated, modified and studied in detail at the biochemical level, much needs to be done at the level of hybrid structures with interfaces to inorganic materials. Further, scaling laws need to be understood in order to bridge between single molecules and higher order devices or architectures.

A similar situation is encountered with biomaterials, another area with tremendous application potential. Alongwith these topics, this symposium will also cover the equally important area of biomolecular analysis, which has reached new levels of sensitivity, precision and resolution due to advances in other sciences. Thus, topics scuh as fluidics, detection methods and engineering approaches will receive enhanced attention. Drug design and delivery is poised the interface of several topics such as receptor signaling, computational modeling, targeted design, nanoscale biomaterials and toxicological profiles.

We invite submissions in each of these areas and related topics. A sample listing of pertinent topics is listed below. This is by no means an exclusive list, but aims to give a general overview of this diverse symposium topic.

Topics & Application Areas

Online abstract submissions are now being accepted. Proposed topics include, but are not be limited to:

  • Quantum Dots
  • Polymers
  • Dendrimers
  • DNA-Gold-Nanoparticle Conjugates
  • Fluorescent & Luminescent Particles
  • Nucleic Acid Ligands (aptamers)
  • Targeted Functionalization of Nanoparticles
  • Other

Journal Submissions

Nanomedicine: Nanotechnology, Biology and Medicine (Nanomedicine)

Nanomedicine: Nanotechnology, Biology and Medicine (Nanomedicine)

Nanomedicine: Nanotechnology, Biology and Medicine (Nanomedicine) is a newly established, international, peer-reviewed journal published quarterly. Nanomedicine publishes basic, clinical, and engineering research in the innovative field of nanomedicine. Article categories include basic nanomedicine, diagnostic nanomedicine, experimental nanomedicine, clinical nanomedicine, and engineering nanomedicine, pharmacological nanomedicine.

For consideration into the Nanomedicine: Nanotechnology, Biology and Medicine journal please select the “Submit to Nanomedicine: Nanotechnology, Biology and Medicine” button during the on-line submission procedure. You may only select a single journal during the submission process.

Journal of Experimental Nanoscience

Journal of Experimental Nanoscience

Selected Nanotech Proceedings papers will be reviewed and invited into a Special Issue of the Journal of Experimental Nanoscience. The journal provides a showcase for advances in the experimental sciences underlying nanotechnology and nanomaterials.

For consideration into this Special Issue of the Journal of Experimental Nanoscience, please select the “Submit to Journal of Experimental Nanoscience” button during the on-line submission procedure. You may only select a single journal during the submission process.

Journal of Nanoparticle Research

Journal of Nanoparticle Research

Selected Nanotech Proceedings papers will be reviewed and invited into a Special Issue of Journal of Nanoparticle Research. The journal disseminates knowledge of the physical, chemical and biological phenomena and processes in nanoscale structures.

For consideration into this Special Issue of Journal of Nanoparticle Research, please select the “Submit to Journal of Nanoparticle Research” button during the on-line submission procedure. You may only select a single journal during the submission process.